JY
LUCD icon

Jeff Yass’s Lucid Diagnostics LUCD Stock Holding History

Jeff Yass’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Sell
16,118
-87,056
-84% -$93.8K ﹤0.01% 13071
2026
Q1 		$119K Buy
+103,174
New +$131K ﹤0.01% 12220
2025
Q3 		– Sell
-84,442
Closed -$97.1K – 13253
2025
Q2 		$97.1K Sell
84,442
-106,013
-56% -$137K ﹤0.01% 11814
2025
Q1 		$284K Buy
+190,455
New +$229K ﹤0.01% 10175
2022
Q1 		– Sell
-13,255
Closed -$71K – 13571
2021
Q4 		$71K Buy
+13,255
New +$108K ﹤0.01% 12365

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jeff Yass's LUCD Position: Q2 2026 in Review

Jeff Yass reduced its Lucid Diagnostics (LUCD) stake by 84% in Q2 2026, selling an estimated $93.8K and leaving 16,118 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13071.

Jeff Yass first reported a position in LUCD in Q4 2021 and has held it in 5 quarters since. The position peaked at $284K in Q1 2025. 114 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Jeff Yass held 16,118 shares of Lucid Diagnostics worth $17.2K as of Q2 2026.
  • Jeff Yass sold 87,056 Lucid Diagnostics shares in Q2 2026, an estimated $93.8K.
  • Lucid Diagnostics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13071 holding.
  • Jeff Yass first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 5 quarters since.
  • Jeff Yass's Lucid Diagnostics position peaked at $284K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.